|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8928 USD | -1.21% |
|
+8.00% | -98.86% |
| 07-28 | Onconetix, Inc. announced that it expects to receive $780.2496 million in funding | CI |
| 05-19 | Onconetix, Inc. announces 1-for-10 reverse stock split | RE |
| Market Cap | 3.29M 2.85M 2.66M 2.44M 4.59M 313M 4.66M 31.19M 12.24M 157M 12.36M 12.09M 519M | P/E 2024 * |
-
| P/E 2025 | -0.09x |
|---|---|---|---|---|---|
| Enterprise Value | -1.88M -1.63M -1.52M -1.39M -2.62M -179M -2.66M -17.82M -7M -89.71M -7.06M -6.91M -297M | EV / Sales 2024 |
5,556,319x | EV / Sales 2025 | -3,367,890x |
| Free-Float |
99.83% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Onconetix, Inc.
| 1 day | -1.21% | ||
| 1 week | +8.00% | ||
| Current month | +8.00% | ||
| 1 month | -9.36% | ||
| 3 months | -76.51% | ||
| 6 months | -98.50% | ||
| Current year | -98.86% |
| 1 week | 0.79 |  | 1.01 |
| 1 month | 0.67 | | 1.01 |
| Current year | 0.67 | | 115 |
| 1 year | 0.67 | | 209.5 |
| 3 years | 0.67 | | 169,998.64 |
| 5 years | 0.67 | | 15,452,876.38 |
| 10 years | 0.67 | | 15,452,876.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
David White
CEO | Chief Executive Officer | 73 | 18/03/2026 |
Karina Fedasz
CEO | Chief Executive Officer | 53 | 02/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Simon Tarsh
BRD | Director/Board Member | 64 | 01/08/2022 |
Sarah Romano
BRD | Director/Board Member | 46 | 05/12/2025 |
Sammy Dorf
CHM | Chairman | 41 | 23/04/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/15/25 A | Others | Director | 657 | 0.1259% | ||
| 8/15/25 A | Others | Director | 657 | 0.1259% | ||
| 8/15/25 A | Others | Director | 657 | 0.1259% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.21% | +8.00% | -99.37% | -100.00% | 3.29M | |
| +1.59% | +2.85% | +39.32% | -0.16% | 78.32B | |
| +2.77% | +4.78% | -0.98% | +26.82% | 51.1B | |
| -0.84% | +0.09% | +20.92% | +173.68% | 49.18B | |
| +1.10% | +7.55% | -49.33% | -49.48% | 44.71B | |
| +0.80% | +2.46% | +59.13% | -23.35% | 30.72B | |
| +1.84% | +0.87% | +53.80% | +84.29% | 24.44B | |
| +9.86% | +7.94% | +126.53% | -41.89% | 23.62B | |
| +3.27% | +13.90% | +8.89% | +204.19% | 21.05B | |
| +1.66% | -3.70% | +66.13% | +119.15% | 16.61B | |
| Average | +2.09% | +4.67% | +22.50% | +39.32% | 33.98B | |
| Weighted average by Cap. | +1.98% | +4.29% | +27.25% | +42.13% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.52 2.18 2.04 1.87 3.52 240.22 3.57 23.92 9.39 120.41 9.48 9.27 398.06 | 0.82 0.71 0.66 0.6 1.14 77.6 1.15 7.73 3.03 38.9 3.06 2.99 128.59 |
| Net income | -58.69M -50.77M -47.41M -43.49M -81.8M -5.59B -83.1M -556M -218M -2.8B -220M -216M -9.26B | -14.03M -12.14M -11.34M -10.4M -19.56M -1.34B -19.87M -133M -52.2M -669M -52.69M -51.54M -2.21B |
| Net Debt | 8.8M 7.61M 7.11M 6.52M 12.27M 838M 12.46M 83.41M 32.74M 420M 33.05M 32.33M 1.39B | -5.17M -4.47M -4.18M -3.83M -7.21M -492M -7.32M -49.02M -19.24M -247M -19.42M -19M -816M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | $0.8916 | -1.34% | 104,875 |
| 06/08/26 | $0.9037 | -10.08% | 395,944 |
| 05/08/26 | $1.005 | +20.42% | 391,442 |
| 04/08/26 | $0.8346 | +2.90% | 163,670 |
| 03/08/26 | $0.8111 | -1.89% | 114,274 |
- Stock Market
- Stocks
- ONCO Stock
Select your edition
All financial news and data tailored to specific country editions
